Cagas, Eugenio B.

HRN: 11-61-62  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2026
CEFTRIAXONE 1G (VIAL)
06/06/2026
06/12/2026
IVTT
2g
OD
Cap-MR
Checking Initial Appropriateness 
06/06/2026
AZITHROMYCIN 500MG TABLET (TAB)
06/06/2026
06/10/2026
ORAL
500 Mg/tab, 1 Tab
OD
Cap-MR
Checking Initial Appropriateness 
06/11/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/11/2026
06/18/2026
IV
4.5g
Q6
Cap Hr
Checking Initial Appropriateness 
06/14/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
06/14/2026
06/21/2026
IV
750mg
Q24
Cap Hr
Checking Initial Appropriateness 
06/14/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/14/2026
06/21/2026
IV
400mg
Q24
Cap Hr; Ptb
Checking Initial Appropriateness 
06/21/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/21/2026
06/28/2026
IV
900mg
Q8
Soft Tissue Infection
Checking Initial Appropriateness 
06/21/2026
MUPIROCIN 2%, 15G (TUBE)
06/21/2026
06/28/2026
TOPICAL
2%
BID
Soft Tissue Infectiob
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: